Bronchial Asthma
Respiratory·MeSH: Asthma
Prevalence
8000.0 / 100K
Incidence
400.0 / 100K/yr
2 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| cromolyn | AGILE THERAPEUTICS INC (AGRX) |
Phase 3(1)
| Drug | Company |
|---|---|
| Roflumilast | ASTRAZENECA PLC (AZN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Bronchial Asthma?
BioSniper tracks 2 drugs in development for Bronchial Asthma across 2 companies.
How many clinical trials target Bronchial Asthma?
There are 4 clinical trials targeting Bronchial Asthma tracked by BioSniper.
What is the prevalence of Bronchial Asthma?
The estimated prevalence of Bronchial Asthma is approximately 8000.0 per 100,000 population.
Deep-dive into Bronchial Asthma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis